Delineate

About Delineate

This startup provides an AI-powered co-pilot for quantitative pharmacology, designed to enhance computational modeling in drug development. Its platform leverages large language models to streamline literature workflows, offering tools for multi-source parameter extraction, table and equation extraction, plot digitization, biological mechanism exploration, and model replication.

```xml <problem> Quantitative pharmacology relies on complex computational models, but the process of building and validating these models is often slowed down by manual literature reviews and data extraction. Researchers face challenges in efficiently identifying relevant parameters, extracting data from tables and plots, and replicating existing models. </problem> <solution> This startup offers an AI-powered co-pilot designed to accelerate quantitative pharmacology workflows. The platform uses large language models to automate key steps in model development, including multi-source parameter extraction, table and equation extraction from publications, and plot digitization. By streamlining these tasks, the co-pilot enables researchers to explore biological mechanisms more efficiently and replicate models with greater speed and accuracy. </solution> <features> - AI-driven parameter extraction from scientific literature - Automated table and equation extraction - Plot digitization capabilities - Biological mechanism exploration tools - Model replication functionalities - Integration with existing modeling software </features> <target_audience> The primary target audience includes quantitative pharmacologists, modelers, and researchers in the pharmaceutical industry and academia involved in drug development and computational biology. </target_audience> ```

What does Delineate do?

This startup provides an AI-powered co-pilot for quantitative pharmacology, designed to enhance computational modeling in drug development. Its platform leverages large language models to streamline literature workflows, offering tools for multi-source parameter extraction, table and equation extraction, plot digitization, biological mechanism exploration, and model replication.

Where is Delineate located?

Delineate is based in Llandysul, United Kingdom.

When was Delineate founded?

Delineate was founded in 2017.

Location
Llandysul, United Kingdom
Founded
2017
Employees
53 employees
Investors
Civilization Ventures

Delineate

5
Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

This startup provides an AI-powered co-pilot for quantitative pharmacology, designed to enhance computational modeling in drug development. Its platform leverages large language models to streamline literature workflows, offering tools for multi-source parameter extraction, table and equation extraction, plot digitization, biological mechanism exploration, and model replication.

delineate.pro2K+
Founded 2017Llandysul, United Kingdom

Funding

Backed by

Civilization Ventures

Team (50+)

No team information available.

Company Description

Problem

Quantitative pharmacology relies on complex computational models, but the process of building and validating these models is often slowed down by manual literature reviews and data extraction. Researchers face challenges in efficiently identifying relevant parameters, extracting data from tables and plots, and replicating existing models.

Solution

This startup offers an AI-powered co-pilot designed to accelerate quantitative pharmacology workflows. The platform uses large language models to automate key steps in model development, including multi-source parameter extraction, table and equation extraction from publications, and plot digitization. By streamlining these tasks, the co-pilot enables researchers to explore biological mechanisms more efficiently and replicate models with greater speed and accuracy.

Features

AI-driven parameter extraction from scientific literature

Automated table and equation extraction

Plot digitization capabilities

Biological mechanism exploration tools

Model replication functionalities

Integration with existing modeling software

Target Audience

The primary target audience includes quantitative pharmacologists, modelers, and researchers in the pharmaceutical industry and academia involved in drug development and computational biology.

Sources:

This profile is AI-generated from web data and may contain inaccuracies. Want to correct or remove an entry? Owners can claim edits via their company email domain, and signed-in users can submit sourced suggestions.